Resignation of Wholetime Company Secretary

Kmp ResignedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹41.79

prior close

₹43.69

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+0.5% vs market

Pharmaceuticals peers, median of 154sector-0.2%+0.2% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-6.2

15m

-6.2

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1-0.6+0.5-0.2+0.2

Next day

-1.0-1.1+0.1-0.6-0.3

-1.6-1.6-0.0-0.8-0.8

-1.0-2.7+1.7-1.0+0.0

-1.9-5.0+3.1-3.1+1.2

-0.7-3.1+2.4-2.3+1.6

-4.2-3.3-0.8-2.2-2.0

15d

-17.9-1.8-16.1-1.1-16.8

-6.0-1.2-4.8-0.7-5.3

-4.3-9.0+4.7-7.6+3.4

+10.1-9.7+19.8-10.2+20.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bacil Pharma Ltd has informed BSE that Bhavana Phoolchand Tak has resigned from the position of Company Secretary and Compliance Officer effective close of business hours on 01st December 2025. The reason cited is to pursue an alternate career opportunity outside the organisation. The company has confirmed there are no other material reasons for the resignation. The company is currently in the process of identifying a suitable replacement and will inform the stock exchange once appointed. The resignation has been signed off by Chaitali Kalpataru Shah, Director of the company.

Likely market impact

This is a routine KMP-level exit and not a board or top management change. The company will need to fill the Company Secretary and Compliance Officer role within the timeline required under the Companies Act to avoid any compliance gaps. Minimal direct impact expected on share price.